Profound Medical, Inc.
Profound Medical is dedicated to developing and marketing innovative, incision-free therapies for prostate and other medical conditions. Their mission is to profoundly change the standard of care by creating safe, effective, and minimally invasive treatment options that preserve patients' quality of life. They focus on technologies such as TULSA-PRO® and SONALLEVE®, which utilize real-time MRI guidance and ultrasound energy to deliver precise ablation treatments. The company is committed to advancing healthcare through cutting-edge medical devices and clinical research, with a global presence and a strong emphasis on patient safety and outcomes.
Industries
Nr. of Employees
medium (51-250)
Patents
Multi-channel real-time phase modulation for EMI reduction in an ultrasound device
US-12128256-B2
View DetailsUltrasonic therapy applicator and method of determining position of ultrasound transducers
US-11957937-B2
View DetailsSystem and method for open-loop ultrasound therapy to the prostate including restricting the therapy delivered to a predetermined angular range
US-11944847-B2
View DetailsMulti-channel real-time phase modulation for EMI reduction in an ultrasound device
US-11806554-B2
View Details
Multi-channel real-time phase modulation for EMI reduction in an ultrasound device
US-12128256-B2
View DetailsUltrasonic therapy applicator and method of determining position of ultrasound transducers
US-11957937-B2
View DetailsSystem and method for open-loop ultrasound therapy to the prostate including restricting the therapy delivered to a predetermined angular range
US-11944847-B2
View DetailsMulti-channel real-time phase modulation for EMI reduction in an ultrasound device
US-11806554-B2
View DetailsProducts
MRI-guided transurethral robotic ultrasound ablation system
An MRI-compatible system that delivers directional transurethral thermal ultrasound combined with robotic positioning, real-time MR thermometry, closed-loop temperature control software, and active water cooling to enable customizable prostate ablation.
Extracorporeal MRI-guided focused ultrasound platform
An MRI-integrated extracorporeal focused ultrasound platform for non-invasive thermal ablation in soft tissue and bone, supporting MR-guidance and thermometry and investigational HIFU modes.
MRI-guided transurethral robotic ultrasound ablation system
An MRI-compatible system that delivers directional transurethral thermal ultrasound combined with robotic positioning, real-time MR thermometry, closed-loop temperature control software, and active water cooling to enable customizable prostate ablation.
Extracorporeal MRI-guided focused ultrasound platform
An MRI-integrated extracorporeal focused ultrasound platform for non-invasive thermal ablation in soft tissue and bone, supporting MR-guidance and thermometry and investigational HIFU modes.
Services
Live and recorded webinars, investigator meetings, online clinician education, and patient-facing websites to explain MRI-guided ablation workflows, procedure planning, and patient information.
On-site execution and centralized data reporting for multi-center pivotal studies, including topline data disclosure and support for peer-reviewed publication.
Collaborative site agreements with imaging center operators and health providers to deploy MRI-guided ablation services under recurring-revenue and site-integration models.
Live and recorded webinars, investigator meetings, online clinician education, and patient-facing websites to explain MRI-guided ablation workflows, procedure planning, and patient information.
On-site execution and centralized data reporting for multi-center pivotal studies, including topline data disclosure and support for peer-reviewed publication.
Collaborative site agreements with imaging center operators and health providers to deploy MRI-guided ablation services under recurring-revenue and site-integration models.
Expertise Areas
- MR-guided interventional thermal therapies
- Transurethral ultrasound ablation and robotic applicator control
- MRI-guided extracorporeal focused ultrasound (MRgHIFU)
- Clinical trial design and execution for pivotal device studies
Key Technologies
- Transurethral directional ultrasound therapy
- Real-time MR thermometry
- Closed-loop temperature-feedback control
- MRI-compatible robotic applicator control
News & Updates
The company announced FDA clearance for its TULSA-PRO system for prostate tissue ablation, supported by the TACT clinical trial.
Profound Medical announced the approval of TULSA-PRO® for the treatment of low to intermediate risk prostate cancer in Canada.
Profound Medical signed a multi-center commercial agreement with RadNet to treat patients with TULSA-PRO® in the U.S.
Dr. Lumiani discusses his experience with TULSA-PRO® for prostate cancer and BPH treatment at ALTA Klinik.
A white paper featuring leading experts discussing new strategies and technologies for prostate cancer treatment.
Regulatory approval from the U.S. FDA to market TULSA-PRO® for prostate tissue ablation.
The company announced FDA clearance for its TULSA-PRO system for prostate tissue ablation, supported by the TACT clinical trial.
Profound Medical announced the approval of TULSA-PRO® for the treatment of low to intermediate risk prostate cancer in Canada.
Profound Medical signed a multi-center commercial agreement with RadNet to treat patients with TULSA-PRO® in the U.S.
Dr. Lumiani discusses his experience with TULSA-PRO® for prostate cancer and BPH treatment at ALTA Klinik.
A white paper featuring leading experts discussing new strategies and technologies for prostate cancer treatment.
Regulatory approval from the U.S. FDA to market TULSA-PRO® for prostate tissue ablation.